|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2001-4-24
|
|
pubmed:abstractText |
Oxidized low density lipoprotein (ox-LDL) has been suggested to affect endothelium-dependent vascular tone through a decreased biological activity of endothelium-derived nitric oxide (NO). Oxidative inactivation of NO is regarded as an important cause of its decreased biological activity, and in this context superoxide (O(2)) is known to inactivate NO in a chemical reaction during which peroxynitrite is formed. In this study we examined the effect of ox-LDL on the intracellular NO concentration in bovine aortic endothelial cells and whether this effect is influenced by ox-LDL binding to the endothelial receptor lectin-like ox-LDL receptor-1 (LOX-1) through the formation of reactive oxygen species and in particular of O(2). ox-LDL induced a significant dose-dependent decrease in intracellular NO concentration both in basal and stimulated conditions after less than 1 min of incubation with bovine aortic endothelial cells (p < 0.01). In the same experimental conditions ox-LDL also induced O(2) generation (p < 0.001). In the presence of radical scavengers and anti-LOX-1 monoclonal antibody, O(2) formation induced by ox-LDL was reduced (p < 0.001) with a contemporary rise in intracellular NO concentration (p < 0.001). ox-LDL did not significantly modify the ability of endothelial nitric oxide synthase to metabolize l-arginine to l-citrulline. The results of this study show that one of the pathophysiological consequences of ox-LDL binding to LOX-1 may be the inactivation of NO through an increased cellular production of O(2).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/(3,4-dihydroxyphenylamino)-2-imidazo...,
http://linkedlifedata.com/resource/pubmed/chemical/6-hydroxy-2,5,7,8-tetramethylchroman...,
http://linkedlifedata.com/resource/pubmed/chemical/Allopurinol,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Ascorbic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Chromans,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radical Scavengers,
http://linkedlifedata.com/resource/pubmed/chemical/Hemostatics,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/OLR1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Olr1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Oxygen,
http://linkedlifedata.com/resource/pubmed/chemical/Probucol,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Oxidized LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Scavenger Receptors, Class E,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxides,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine,
http://linkedlifedata.com/resource/pubmed/chemical/oxidized low density lipoprotein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0021-9258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
276
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13750-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11278710-Humans,
pubmed-meshheading:11278710-Animals,
pubmed-meshheading:11278710-Mice,
pubmed-meshheading:11278710-Ascorbic Acid,
pubmed-meshheading:11278710-Oxygen,
pubmed-meshheading:11278710-Cattle,
pubmed-meshheading:11278710-Nitric Oxide,
pubmed-meshheading:11278710-Thrombin,
pubmed-meshheading:11278710-Aorta,
pubmed-meshheading:11278710-Catecholamines,
pubmed-meshheading:11278710-Reactive Oxygen Species,
pubmed-meshheading:11278710-Enzyme Inhibitors,
pubmed-meshheading:11278710-Cricetinae,
pubmed-meshheading:11278710-Imidazolines,
pubmed-meshheading:11278710-Aspirin,
pubmed-meshheading:11278710-Hemostatics,
pubmed-meshheading:11278710-Chromans,
pubmed-meshheading:11278710-Antioxidants,
pubmed-meshheading:11278710-Time Factors,
pubmed-meshheading:11278710-Cells, Cultured,
pubmed-meshheading:11278710-Bradykinin,
pubmed-meshheading:11278710-Endothelium, Vascular,
pubmed-meshheading:11278710-Protein Binding,
pubmed-meshheading:11278710-Allopurinol,
pubmed-meshheading:11278710-CHO Cells,
pubmed-meshheading:11278710-Dose-Response Relationship, Drug,
pubmed-meshheading:11278710-Lipoproteins, LDL,
pubmed-meshheading:11278710-Probucol,
pubmed-meshheading:11278710-Free Radical Scavengers,
pubmed-meshheading:11278710-Superoxides,
pubmed-meshheading:11278710-Antibodies, Monoclonal,
pubmed-meshheading:11278710-Flow Cytometry,
pubmed-meshheading:11278710-Receptors, LDL,
pubmed-meshheading:11278710-omega-N-Methylarginine,
pubmed-meshheading:11278710-Receptors, Oxidized LDL,
pubmed-meshheading:11278710-Scavenger Receptors, Class E
|
